Back to Results
First PageMeta Content
Investment / Funds / Financial risk / Private equity / Corporate finance / Venture capital / Capital structure / Collective investment scheme / Institutional investor / Financial economics / Economics / Finance


Frequently Asked Questions About “Commercializing Biomedical Research Through Securitization Techniques” By Jose-Maria Fernandez, Roger M. Stein, Andrew W. Lo Latest Revision: November 5, 2012 Since the publication o
Add to Reading List

Document Date: 2012-11-06 12:40:01


Open Document

File Size: 237,05 KB

Share Result on Facebook

City

Toronto / New York / /

Company

Roche Holdings / Royalty Pharma / DRI Capital / Cowen Healthcare / Genentech / /

Country

United States / /

Currency

USD / /

Event

M&A / Environmental Issue / Debt Financing / Funding / /

Facility

Milken Institute / /

IndustryTerm

biotech venture capital / venture capital / greater infrastructure / finance projects / healthcare laws / medical technologies / retail versions / pharmaceutical industry / clean-energy technologies / life insurance firms / cancer therapeutics / insurance reimbursement policies / energy research / pharmaceutical / sustainable food production / simulation software / finance journal / retail investors / /

MedicalCondition

cancer / cancer RBO / tumors / disease / distinct diseases / single disease / target disease / diseases / improved cancer / /

MedicalTreatment

cancer therapeutics / /

Organization

MIT / FDA / Milken Institute / Kauffman Foundation for Entrepeneurship / /

Person

Jose-Maria Fernandez / Roger M. Stein / Andrew W. Lo / /

Position

portfolio manager / distributive partnering model for drug development / representative / megafund manager / biopharma mutual fund manager / /

PublishedMedium

Nature Biotechnology / /

Technology

Biotechnology / simulation / drug development / clean-energy technologies / /

URL

http /

SocialTag